QIAGEN (QGEN)
(Delayed Data from NYSE)
$42.09 USD
-0.54 (-1.27%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $42.10 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Price, Consensus and EPS Surprise
QGEN 42.09 -0.54(-1.27%)
Will QGEN be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for QGEN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for QGEN
QGEN Collaborates With McGill University Centre: Stock to Gain?
Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock
QGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock?
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up
Other News for QGEN
Qiagen Larger Than S&P 500 Component Federal Realty Investment Trust
Qiagen enters three-year partnership with McGill University
Qiagen enters three-year partnership with McGill University
Notable Tuesday Option Activity: QGEN, NUE, SNDX
UBS Remains a Hold on Qiagen (QGEN)